文献速递免疫规划

含佐剂的H7N9 LAH-HBc病毒样颗粒疫苗可保护小鼠抵抗同源和异源流感病毒

Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses.
PubMed 文献 · Vaccine · 2016-11-17

研究将H7N9流感病毒血凝素长α螺旋(LAH)区插入乙肝核心蛋白(HBc),在大肠杆菌表达系统中制备可自组装为病毒样颗粒(VLP)的LAH-HBc蛋白。小鼠鼻内免疫LAH-HBc VLP联合壳聚糖佐剂或CTB*佐剂可有效诱导体液和细胞免疫应答,对同源H7N9或异源H3N2致死性攻击提供完全保护,对异源H1N1致死性攻击提供部分保护。

要点

  • LAH-HBc VLP联合壳聚糖或CTB*佐剂鼻内免疫小鼠可诱导体液和细胞免疫。
  • 该疫苗对同源H7N9和异源H3N2致死性攻击提供完全保护。
  • 该疫苗对异源H1N1致死性攻击仅提供部分保护。

核心结论

  • 研究结果为LAH-HBc VLP疫苗提供了概念验证,该疫苗生产快速简便,可能成为应对未来流感大流行的理想快速反应候选工具。

研究设计与样本

  • 研究将H7N9流感病毒HA的LAH区插入HBc,利用大肠杆菌表达系统制备可自组装为VLP的LAH-HBc蛋白,并在小鼠中鼻内免疫评估联合壳聚糖佐剂或CTB*佐剂的效果。

主要发现

  • 小鼠鼻内免疫LAH-HBc VLP联合壳聚糖佐剂或CTB*佐剂可有效诱导体液和细胞免疫应答。
  • 该免疫对同源H7N9病毒或异源H3N2病毒致死性攻击提供完全保护。
  • 该免疫对异源H1N1病毒致死性攻击提供部分保护。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The long alpha-helix (LAH) region located in influenza virus hemagglutinin (HA) shows conservation among different influenza A strains, which could be used as a candidate target of influenza vaccines. Moreover, the hepatitis B virus core protein (HBc) is a carrier for heterologous epitopes in eliciting effective immune responses. We inserted the LAH region of H7N9 influenza virus into the HBc and prepared the LAH-HBc protein, which were capable of self-assembly into virus-like particles (VLP), by using E. coli expression system. Intranasal immunization of the LAH-HBc VLP in combination with chitosan adjuvant or CTB∗ adjuvant in mice could induce both humoral and cellular immune responses effectively and provide complete protection against lethal challenge of homologous H7N9 virus or heterologous H3N2 virus, as well as partial protection against lethal challenge of heterologous H1N1 virus. These results provide a proof of concept for LAH-HBc VLP vaccine that would be fast and easy to be produced and might be an ideal candidate as a rapid-response tool against a future influenza pandemic.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zheng D, Chen S, Qu D, et al. Influenza H7N9 LAH-HBc virus-like particle vaccine with adjuvant protects mice against homologous and heterologous influenza viruses. Vaccine. 2016. PMID: 27866773. doi:10.1016/j.vaccine.2016.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。